Viral load as predictor of Crimean-Congo hemorrhagic fever outcome

Emerging Infectious Diseases

Volumn 13, Issue 11, 2007, Pages 1769-1772

  Duh, Darja ^a   Saksida, Ana ^a   Petrovec, Miroslav ^a   Ahmeti, Salih ^b   Dedushaj, Iusuf ^c   Panning, Marcus ^d   Drosten, Christian ^d   Avšič Županc, Tatjana ^a,e  

^a Institute of Microbiology and Immunology   (Slovenia)

^b Clinic of Infectious Diseases   (Macedonia)

^c National Institute of Public Health   (Serbia)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NAIRO VIRUS; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS DETECTION; VIRUS HEMORRHAGIC FEVER; VIRUS LOAD;

EID: 36248954045     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1311.070222     Document Type: Article

References (12)

1. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203-14.
2. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006;12:551-4.
3. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004;39:284-7.
4. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11:S794-800.
5. Schutten M, Niesters HG. Clinical utility of viral quantification as a tool for disease monitoring. Expert Rev Mol Diagn. 2001;1:153-62.
6. Kumar M, Jain S, Sharma BC, Sarin SK. Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B. Dig Dis Sci. 2006;51:594-9.
7. Lavreys L, Baeten JM, Chohan V, McClelland RS, Hassan WM, Richardson BA, et al. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis. 2006;42:1333-9.
8. Boeckh M, Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev. 1998;11:533-54.
9. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004;78:4330-41.
10. Duh D, Saksida A, Petrovec M, Dedushaj I, Avsic-Zupanc T. Novel one-step real-time RT-PCR assay for rapid and specific diagnosis of Crimean-Congo hemorrhagic fever encountered in the Balkans. J Virol Methods. 2006;133:175-9.
11. Drosten C, Panning M, Drexler JF, Hansel F, Pedroso C, Yeats J, et al. Ultrasensitive monitoring of HIV-1 viral load by a low-cost realtime reverse transcription-PCR assay with internal control for the 5′ long terminal repeat domain. Clin Chem. 2006;52:1258-66.
12. Chen LH, Wilson ME. Transmission of dengue virus without a mosquito vector: nosocomial mucocutaneous transmission and other routes of transmission. Clin Infect Dis. 2004;39:56-60.